Surfactant protein A2 mutations associated with pulmonary fibrosis lead to protein instability and endoplasmic reticulum stress.
Rare heterozygous mutations in the gene encoding surfactant protein A2 (SP-A2, SFTPA2) are associated with adult-onset pulmonary fibrosis and adenocarcinoma of the lung. We have previously shown that two recombinant SP-A2 mutant proteins (G231V and F198S) remain within the endoplasmic reticulum (ER) of A549 cells and are not secreted into the culture medium. The pathogenic mechanism of the mutant proteins is unknown. Here we analyze all common and rare variants of the surfactant protein A2, SP-A2, in both A549 cells and in primary type II alveolar epithelial cells. We show that, in contrast with all other SP-A2 variants, the mutant proteins are not secreted into the medium with wild-type SP-A isoforms, form fewer intracellular dimer and trimer oligomers, are partially insoluble in 0.5% Nonidet P-40 lysates of transfected A549 cells, and demonstrate greater protein instability in chymotrypsin proteolytic digestions. Both the G231V and F198S mutant SP-A2 proteins are destroyed via the ER-association degradation pathway. Expression of the mutant proteins increases the transcription of a BiP-reporter construct, expression of BiP protein, and production of an ER stress-induced XBP-1 spliced product. Human bronchoalveolar wash samples from individuals who are heterozygous for the G231V mutation have similar levels of total SP-A as normal family members, which suggests that the mechanism of disease does not involve an overt lack of secreted SP-A but instead involves an increase in ER stress of resident type II alveolar epithelial cells.
Maitra
Meenakshi
M
Eugene McDermott Center for Human Growth and Development, Dallas, Texas 75390, USA.
Wang
Yongyu
Y
Gerard
Robert D
RD
Mendelson
Carole R
CR
Garcia
Christine Kim
CK
D019943:Amino Acid Substitution / Q000187:drug effects; D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D002457:Cell Extracts; D045744:Cell Line, Tumor; D003902:Detergents / Q000494:pharmacology; D004285:Dogs; D004721:Endoplasmic Reticulum / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology*; D005260:Female; D006801:Humans; D007976:Leupeptins / Q000494:pharmacology; D008297:Male; D050505:Mutant Proteins / Q000378:metabolism; D009154:Mutation / Q000235:genetics*; D010375:Pedigree; D011499:Protein Processing, Post-Translational / Q000187:drug effects; D055550:Protein Stability / Q000187:drug effects; D020836:Protein Structure, Quaternary; D011650:Pulmonary Alveoli / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D011658:Pulmonary Fibrosis / Q000235:genetics* / Q000473:pathology* / Q000503:physiopathology; D037662:Pulmonary Surfactant-Associated Protein A / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D012995:Solubility / Q000187:drug effects; D013312:Stress, Physiological / Q000187:drug effects
D015415:Biomarkers; D002457:Cell Extracts; D003902:Detergents; D007976:Leupeptins; D050505:Mutant Proteins; D037662:Pulmonary Surfactant-Associated Protein A; C445842:SFTPA1 protein, human; C445843:SFTPA2 protein, human; C072553:benzyloxycarbonylleucyl-leucyl-leucine aldehyde
Nat Rev Immunol. 2005 Jan;5(1):58-68
15630429
Biochim Biophys Acta. 1998 Nov 19;1408(2-3):296-302
9813377
Br J Cancer. 2004 Aug;91 Suppl 2:S3-10
15340372
J Biol Chem. 2003 Dec 26;278(52):52739-46
14525980
Mol Cell. 1998 Oct;2(4):505-14
9809072
Am J Respir Cell Mol Biol. 1998 Aug;19(2):202-9
9698591
J Clin Invest. 2005 Oct;115(10):2656-64
16200199
Am J Physiol. 1989 Dec;257(6 Pt 1):L421-9
2610270
J Clin Invest. 2002 Mar;109(6):707-12
11901176
Comp Biochem Physiol A Mol Integr Physiol. 2001 May;129(1):109-27
11369537
J Cell Sci. 2003 Feb 15;116(Pt 4):683-92
12538769
Biochemistry. 2004 Apr 13;43(14):4227-39
15065867
Am J Respir Cell Mol Biol. 2005 Jun;32(6):521-30
15778495
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2009 Dec;23(12):1409-12
20073298
Am J Respir Crit Care Med. 2008 Oct 15;178(8):838-46
18635891
Biochem J. 2007 Sep 15;406(3):479-89
17542781
Anal Biochem. 1978 Nov;91(1):350-3
9762117
Respirology. 2006 Jan;11 Suppl:S12-5
16423262
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7552-7
17460043
N Engl J Med. 2002 Dec 26;347(26):2141-8
12501227
Mol Med. 1999 Apr;5(4):224-31
10448644
J Biol Chem. 2003 Oct 31;278(44):43254-60
12913002
Am J Respir Cell Mol Biol. 1997 Dec;17(6):672-82
9409554
Annu Rev Physiol. 2005;67:663-96
15709974
Am J Respir Crit Care Med. 2008 Oct 1;178(7):729-37
18635888
Am J Hum Genet. 2009 Jan;84(1):52-9
19100526
Am J Respir Cell Mol Biol. 1998 Oct;19(4):613-21
9761758
Proc Natl Acad Sci U S A. 1982 Mar;79(6):1889-92
6952238
Infect Immun. 2003 Mar;71(3):1306-15
12595446
Am J Respir Crit Care Med. 2002 May 1;165(9):1322-8
11991887
J Cell Biol. 2006 Jan 30;172(3):395-407
16449190
Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L720-9
17586700
Am J Physiol. 1994 Apr;266(4 Pt 1):L367-74
8179013
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9594-9
8790375
Biochim Biophys Acta. 1998 Nov 19;1408(2-3):312-22
9813381
N Engl J Med. 2007 Mar 29;356(13):1317-26
17392301